• Chemomab director Neil Harris Cohen sold 2,304 American Depositary Shares on Aug. 27-28 at USD 2.8-2.85.
• Directly held stake fell to 33,000 American Depositary Shares following the transactions.
• Form 4 also reported 18,075 stock options outstanding for American Depositary Shares, with exercise prices ranging from USD 2.14 to USD 109.04.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemomab Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004371), on September 01, 2026, and is solely responsible for the information contained therein.